Imatinib Terminated Phase 1 / 2 Trials for Prostate Cancer / Prostatic Neoplasms Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1 / 2
clinicaltrials.gov IdentifierTitleDrugs